Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CASTAGNA L")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 38

  • Page / 2
Export

Selection :

  • and

PINDARO, FR. 169 SN.: INTERPRETAZIONE E PROPOSTA DI DATAZIONE PINDARE, FR. 169 SN: INTERPRETATION ET PROPOSITION DE DATATIONCASTAGNA L.STUD. ITAL. FILOL. CL. 1971, Vol 43, Num 2, pp 173-198Article

L'esametro di Marco ValerioCASTAGNA, L.Studi Medievali Firenze. 1981, Vol 22, Num 2, pp 805-819Article

Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management?CASTAGNA, L; MARTINO, M.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 2, issn 0268-3369, p. 305Article

OSSERVAZIONI SULLA INCIDENZA DELLE CHETOSI E DELLE NEUROSI PUERPERALI DELLE BOVINE, IN RAPPORTO ALL'ALIMENTAZIONE CON MAIS (FORAGGIO O INSILATO) = OBSERVATIONS SUR LA FREQUENCE DE LA CETOSE ET DE LA NEUROPATHIE PUERPERALE DE LA VACHE, EN RAPPORT AVEC L'ALIMENTATION AU MAISSIGNORINI G; CALDARINI L; CASTAGNA L et al.1976; CLIN. VETER.; ITAL.; DA. 1976; VOL. 99; NO 2; PP. 52-56; BIBL. 3 REF.Article

Distribution of an endogenous 16-kd S-lac lectin in the chicken retinaCASTAGNA, L. F; LANDA, C. A.Investigative ophthalmology & visual science. 1994, Vol 35, Num 13, pp 4310-4316, issn 0146-0404Article

Recent progress in the biology of multiple myeloma and future directions in the treatmentPICO, J. L; CASTAGNA, L; BOURHIS, J. H et al.Hematology and cell therapy (Print). 1998, Vol 40, Num 2, pp 45-61, issn 1269-3286Conference Paper

Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host diseaseCASTAGNA, L; NOZZA, A; BERTUZZI, A et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 12, pp 1155-1156, issn 0268-3369Article

Lack of activity of allogeneic stem cell transplantation with reduced-intensity conditioning regimens in advanced sarcomasCASTAGNA, L; SARINA, B; TODISCO, E et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 4, pp 421-422, issn 0268-3369, 2 p.Article

Immunocytochemical study of the distribution of a 16-kDa galectin in the chicken retinaMALDONADO, C. A; CASTAGNA, L. F; RABINOVICH, G. A et al.Investigative ophthalmology & visual science. 1999, Vol 40, Num 12, pp 2971-2977, issn 0146-0404Article

Prevention of mucositis in bone marrow transplantation : A double blind randomised controlled trial of sucralfateCASTAGNA, L; BENHAMOU, E; PEDRAZA, E et al.Annals of oncology. 2001, Vol 12, Num 7, pp 953-955, issn 0923-7534Article

Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphomaMAGAGNOLI, M; SARINA, B; BALZAROTTI, M et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 10, pp 923-927, issn 0268-3369Article

In vitro antioxidant properties of amifostine (WR-2721, Ethyol)MARZATICO, F; PORTA, C; MORONI, M et al.Cancer chemotherapy and pharmacology. 2000, Vol 45, Num 2, pp 172-176, issn 0344-5704Article

Retinoic acid syndrome (RAS) in an aplasic patient with secondary acute promyelocytic leukemia (APL)CASTAGNA, L; BENDAHAMANE, T; BOURHIS, J. H et al.European journal of haematology. 1996, Vol 57, Num 5, pp 392-393, issn 0902-4441Article

Altered natural killer cell differentiation in CD34+ progenitors from Chronic Myeloid Leukemia patientsCARAYOL, G; GIRON-MICHEL, J; AZZARONE, B et al.Oncogene (Basingstoke). 2000, Vol 19, Num 23, pp 2758-2766, issn 0950-9232Article

Reduced plasma concentrations of transforming growth factor β1 (TGF-β1) in obese womenCORICA, F; ALLEGRA, A; BUEMI, M et al.International journal of obesity. 1997, Vol 21, Num 8, pp 704-707, issn 0307-0565Article

First-line extracorporeal photochemotherapy for acute GVHD after unmanipulated haploidentical BMT following nonmyeloablative conditioning and post transplantation CYCASTAGNA, L; MORABITO, L; MAURO, E et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 2, pp 317-318, issn 0268-3369, 2 p.Article

TLI in refractory chronic GVHDDEVILLIER, R; CASTAGNA, L; GONZAGUE, L et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 6, pp 854-858, issn 0268-3369, 5 p.Article

Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumorsPICO, J. L; IBRAHIM, A; CASTAGNA, L et al.Oncology. 1993, Vol 50, pp 47-52, issn 0030-2414, SUP2Conference Paper

Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCTCASTAGNA, L; FÜRST, S; BLAISE, D et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 7, pp 1000-1005, issn 0268-3369, 6 p.Article

Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTCASTAGNA, L; BOUBDALLAH, R; CALMELS, B et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 6, pp 794-798, issn 0268-3369, 5 p.Article

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCTDEVILLIER, R; CROCCHIOLO, R; ESTERNI, B et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 5, pp 639-645, issn 0268-3369, 7 p.Article

Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell supportCASTAGNA, L; BRAMANTI, S; SANTORO, A et al.Annals of oncology. 2010, Vol 21, Num 7, pp 1482-1485, issn 0923-7534, 4 p.Article

Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamideBALZAROTTI, M; SPINA, M; NOZZA, A et al.Annals of oncology. 2002, Vol 13, Num 9, pp 1341-1346, issn 0923-7534, 6 p.Article

Reduced-intensity conditioning regimen with in vivo T-cell depletion for patients with haematological malignancies: results using unrelated and sibling donorsCASTAGNA, L; CROCCHIOLO, R; CHARBONNIER, A et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 9, pp 1246-1247, issn 0268-3369, 2 p.Article

IGEV regimen and a fixed dose of lenograstim : an effective mobilization regimen in pretreated Hodgkin's lymphoma patientsMAGAGNOLI, M; SPINA, M; SANTORO, A et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 11, pp 1019-1025, issn 0268-3369, 7 p.Article

  • Page / 2